tirzepatide 1 mg FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Tirzepatide We Treat – MedResults
Description
Disclaimer: This is a prescription medication for medical use only
It mimics the function of the natural GLP-1 hormone in the body, which is involved in appetite regulation and insulin secretion
Novo Nordisk is evaluating a long-acting semaglutide implant designed to keep GLP-1 patients on treatment for months at a time and food and drink manufacturers should be watching closely.
Low-cost GLP-1
Side effects of Wegovy (semaglutide) include nausea, vomiting, diarrhea, constipation or stomach pain
